Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Natixis Advisors LLC

Natixis Advisors LLC trimmed its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 13.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 61,274 shares of the company’s stock after selling 9,785 shares during the quarter. Natixis Advisors LLC’s holdings in Bath & Body Works were worth $1,956,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the business. Empowered Funds LLC lifted its stake in Bath & Body Works by 68.0% during the third quarter. Empowered Funds LLC now owns 26,462 shares of the company’s stock valued at $845,000 after purchasing an additional 10,711 shares during the last quarter. KBC Group NV lifted its position in shares of Bath & Body Works by 9,023.5% during the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock valued at $54,322,000 after acquiring an additional 1,683,160 shares during the last quarter. Oppenheimer & Co. Inc. lifted its position in shares of Bath & Body Works by 4.5% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 28,535 shares of the company’s stock valued at $911,000 after acquiring an additional 1,231 shares during the last quarter. MQS Management LLC bought a new stake in shares of Bath & Body Works during the 3rd quarter worth $241,000. Finally, Missouri Trust & Investment Co acquired a new position in shares of Bath & Body Works in the 3rd quarter worth $1,178,000. Institutional investors own 95.14% of the company’s stock.

Insider Activity at Bath & Body Works

In other news, CEO Gina Boswell bought 6,000 shares of Bath & Body Works stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the completion of the transaction, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.27% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on BBWI shares. Robert W. Baird dropped their price target on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a research note on Thursday, August 29th. Telsey Advisory Group restated an “outperform” rating and set a $42.00 price target on shares of Bath & Body Works in a report on Monday. Barclays lowered shares of Bath & Body Works from an “equal weight” rating to an “underweight” rating and decreased their price objective for the stock from $31.00 to $28.00 in a research note on Friday, November 8th. BMO Capital Markets reissued an “outperform” rating and set a $50.00 target price (down from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. Finally, Wells Fargo & Company decreased their target price on Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $42.25.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $35.78 on Tuesday. Bath & Body Works, Inc. has a 52 week low of $26.20 and a 52 week high of $52.99. The firm has a market capitalization of $7.84 billion, a PE ratio of 8.66, a PEG ratio of 0.98 and a beta of 1.79. The business’s 50-day simple moving average is $30.69 and its 200-day simple moving average is $35.74.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. Research analysts forecast that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.24%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s payout ratio is presently 19.37%.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.